Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms

The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous ope...

Full description

Saved in:
Bibliographic Details
Published inProgress in Nucleic Acid Research and Molecular Biology Vol. 70; pp. 33,IN1,55 - 54,IN2,75
Main Authors Roche, Thomas E., Baker, Jason C., Yan, Xiaohua, Hiromasa, Yasuaki, Gong, Xiaoming, Peng, Tao, Dong, Jianchun, Turkan, Ali, Kasten, Shane A.
Format Book Chapter Journal Article
LanguageEnglish
Published United States Elsevier Science & Technology 2001
Subjects
Online AccessGet full text
ISBN0125400705
9780125400701
ISSN0079-6603
DOI10.1016/S0079-6603(01)70013-X

Cover

Abstract The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is acomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes.
AbstractList The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is acomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes.
The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg super(2+) dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is acomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca super(2+)sensitive tissues by elevating PDP1 activity via the Ca super(2+)dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes. PDC, pyruvate dehydrogenase complex; PDK, pyruvate dehyorogenase kinase; PDP, pyruvate dehydrogenase phosphatase; E1, pyruvata dehydrogenase; E2, dihydrolipoyl acetyitransferase; L1, N-terminal lipoyi domain of E2; L2, inner lipoyl domain of E2; E3, dihydrolipoyl dehydrogenase; E3BP, E3-binding protein (formerly protein X); L3, lipoyl domain of E3BP; GST, glutathione-S-transfenase; OCA, dichloroacetate; PPAR-a, peroxisome proliferator-activated receptor-a.
The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the continuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is accomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes.
The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the continuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is accomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes.The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the continuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is accomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes.
Author Roche, Thomas E.
Baker, Jason C.
Peng, Tao
Dong, Jianchun
Yan, Xiaohua
Hiromasa, Yasuaki
Kasten, Shane A.
Turkan, Ali
Gong, Xiaoming
Author_xml – sequence: 1
  givenname: Thomas E.
  surname: Roche
  fullname: Roche, Thomas E.
– sequence: 2
  givenname: Jason C.
  surname: Baker
  fullname: Baker, Jason C.
– sequence: 3
  givenname: Xiaohua
  surname: Yan
  fullname: Yan, Xiaohua
– sequence: 4
  givenname: Yasuaki
  surname: Hiromasa
  fullname: Hiromasa, Yasuaki
– sequence: 5
  givenname: Xiaoming
  surname: Gong
  fullname: Gong, Xiaoming
– sequence: 6
  givenname: Tao
  surname: Peng
  fullname: Peng, Tao
– sequence: 7
  givenname: Jianchun
  surname: Dong
  fullname: Dong, Jianchun
– sequence: 8
  givenname: Ali
  surname: Turkan
  fullname: Turkan, Ali
– sequence: 9
  givenname: Shane A.
  surname: Kasten
  fullname: Kasten, Shane A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11642366$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v1DAQho0o0N3CTwDlhOAQGH_EcU4IteVDqsQBkPZmOfaka5qNg-1U2n-Pd1s4cOlpNNIz73y9a3IyhQkJeUnhHQUq338HaLtaSuBvgL5tASivN4_IGkBBw1jL5OOSUNaIAkJzQlb_Cp6SlWgltJxRfkrWKf0CYG0H8hk5pVQKxqVckc2FT9lPNlcRr5fR5BD31RzDjDF7TFUYqnkfl1uTsXK43bsYrnEyCasbfwxmctW8DWnemnzIfQpDiLv0nDwZzJjwxX08Iz8_Xf44_1Jfffv89fzjVY2C81xbVcYY0IBiahgYUpC246LpmcCe876THYUenOM49IJT66SCoVGmYQ5bafgZeX2nW4b-vWDKeueTxXE0E4Yl6ZaV_RWTD4JCdZIxIR4EGQUhhGIFfHUPLv0OnZ6j35m413-vWwD6nxL2IdxYnHI0o92aOWMsgl1Znmqq9LH7h7saLEe79Rh1sh4ni85HtFm74DUFfXCHPrpDH56tgeqjO_SG_wGE_Kn0
ContentType Book Chapter
Journal Article
Copyright 2001
Copyright_xml – notice: 2001
DBID FFUUA
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7S9
L.6
7X8
DEWEY 572.8
DOI 10.1016/S0079-6603(01)70013-X
DatabaseName ProQuest Ebook Central - Book Chapters - Demo use only
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nucleic Acids Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList
Nucleic Acids Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISBN 0080522726
9780080522722
EndPage 54,IN2,75
ExternalDocumentID 11642366
EBC298281_18_44
S007966030170013X
Genre Research Support, U.S. Gov't, P.H.S
Review
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: DK18320
GroupedDBID --K
--Z
-~X
.55
.GJ
0R~
123
3O-
53G
5RE
85S
8N7
8NA
8NF
AAXUO
AAYSV
ABGWT
ABMAC
ABQQC
ABSWN
ACGFS
ACXMD
ADOJD
AFDAS
AFFNX
AFOST
AFTJW
AGAMA
AHPSJ
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
CS3
DU5
F5P
FDB
G8K
HZ~
H~9
JDP
MVM
O9-
SBF
SDK
SES
SHL
VQA
WH7
X7M
XOL
YNT
ZGI
ZKB
ZXP
089
20A
38.
A4I
A4J
AAAAS
AABBV
AAORS
AAVWF
ADVLN
AHMUE
ALOFI
ALTAS
AZZ
BBABE
CZZ
FFUUA
HGY
MYL
AALRI
ABDPE
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
7TM
ADXHL
AHDLI
7S9
L.6
7X8
ID FETCH-LOGICAL-e433t-c8366fea0828ff2e106c9345b24eb33b96910b0dd3efb431cd680f58a52de76a3
IEDL.DBID HGY
ISBN 0125400705
9780125400701
ISSN 0079-6603
IngestDate Thu Jul 10 22:24:51 EDT 2025
Fri Jul 11 09:52:37 EDT 2025
Fri Jul 11 11:22:15 EDT 2025
Wed Feb 19 01:26:33 EST 2025
Thu May 29 19:45:58 EDT 2025
Fri Feb 23 02:29:58 EST 2024
IsPeerReviewed false
IsScholarly false
Keywords DCA
L1
L2
L3
GST
E1
E2
PDC
E3
PDK
E3BP
PPAR-α
PDP
LCCallNum QP620.P76eb vol. 70
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-e433t-c8366fea0828ff2e106c9345b24eb33b96910b0dd3efb431cd680f58a52de76a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
OCLC 476073213
PMID 11642366
PQID EBC298281_18_44
PQPubID 23462
PageCount 22
ParticipantIDs proquest_miscellaneous_72213826
proquest_miscellaneous_48962244
proquest_miscellaneous_21044482
pubmed_primary_11642366
proquest_ebookcentralchapters_298281_18_44
elsevier_sciencedirect_doi_10_1016_S0079_6603_01_70013_X
PublicationCentury 2000
PublicationDate 2001
2001-00-00
20010101
PublicationDateYYYYMMDD 2001-01-01
PublicationDate_xml – year: 2001
  text: 2001
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Progress in Nucleic Acid Research and Molecular Biology
PublicationTitleAlternate Prog Nucleic Acid Res Mol Biol
PublicationYear 2001
Publisher Elsevier Science & Technology
Publisher_xml – name: Elsevier Science & Technology
SSID ssj0027906
ssj0000228915
Score 1.5659925
SecondaryResourceType review_article
Snippet The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of...
SourceID proquest
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 33,IN1,55
SubjectTerms Amino Acid Sequence
Animals
Biochemistry
Biophysics
Isoenzymes - chemistry
Isoenzymes - physiology
isozymes
Microbiology (non-medical)
Molecular Sequence Data
Protein Kinases - chemistry
Protein Kinases - physiology
Protein-Serine-Threonine Kinases
Pyruvate Dehydrogenase (Lipoamide)-Phosphatase - chemistry
Pyruvate Dehydrogenase (Lipoamide)-Phosphatase - physiology
pyruvate kinase
Sequence Homology, Amino Acid
Title Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms
URI https://dx.doi.org/10.1016/S0079-6603(01)70013-X
http://ebookcentral.proquest.com/lib/SITE_ID/reader.action?docID=298281&ppg=44
https://www.ncbi.nlm.nih.gov/pubmed/11642366
https://www.proquest.com/docview/21044482
https://www.proquest.com/docview/48962244
https://www.proquest.com/docview/72213826
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7yuIRc0m7TbtOmOpTSBkxWki3bx5A2XbqQQ2iocxKyJbNLqG283sD--8zI3iw5pIeCwdjoYX96zIw08wngs3GlIiKwILUWDZRC2MCgGAhQtqF8R5kWld7b4lpNb8NfWZTtwOUmFobcKoe5v5_T_Ww9vDkf0DxvFguK8Y2JWlISAwwqMtku7OPAVXSMwfTn3dNCCxG8pHxLwBen_sBNyh1Qds-zg2YSEd9EAyXP5plvY376-nyOrxP-zVcZZM9E2EsqqhdVV0dwSOELjOIKELJXsOOq1zC6qNC4_rtmX5h3-fRr6SPIvtMIr4qOtf2R9HW7Zg0tz7fEs8rqkjXrdvWA-iizbr62bY39DeUeu1_4m6ksa-b1spmbjp4Xy5qU4OUbuL368ftyGgxHLQQulLILikQqVTpDhHZlKRwaikUqwygXIVrbMk8VqhX5xFrpyhx1jsKqZFJGiYmEdbEy8hj2qrpy74CJPLaxUolE0yvkQqRYmpEm4nluZCzcGJINZPpZS2ucxPXW6QzR1oS2nnDt0dbZGM42EGu_lzw4sBY9pEstUvx-rnmiw3AMn54S45ChfRBTuXqFqTiR5CXi5RRhkirUbf5RRiwEsTeqMbztm1o3PTsImlRo0iGa7___P0_goHd1o-sD7HXtyn1E3afLT2H_YnbzZ3bq-_gjiTT6rQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcgBxKRToUqA-IARIUdePOMkR9cECpadWCifLiR3tCpFE2Wyl_fedcbJd9VAOSJGiRH4knx8zY898BvhgfaWJCCzKnEMDpRQusigGIpRtKN9RpsVV8La41LNr9SOP8x042cTCkFvlOPcPc3qYrcc3xyOax-1iQTG-CVFLSmKAQUUmfwSPFQpHItCffft9t9BCBC8Z3xLwJVk4cJNyR5Q98OygmUTEN_FIybN55tuYn6G-kOPTlH8OVUb5PRH2kIoaRNX5Hjyj8AVGcQUI2XPY8fUL2P9ao3H9d80-suDyGdbS9yE_pRFelz3rhiPpm27NWlqe74hnlTUVa9fd6gb1Ueb8fO26Bvsbyj32ZxFutnasnTfLdm57el4sG1KCly_h-vzs6mQWjUctRF5J2UdlKrWuvCVCu6oSHg3FMpMqLoRCa1sWmUa1opg6J31VoM5ROp1Oqzi1sXA-0Va-gt26qf0BMFEkLtE6lWh6KS5EhqVZaWNeFFYmwk8g3UBm7rW0wUncbJ3OEG1DaJspNwFtk0_gywZiE_aSRwfWcoB0aUSG388NT41SEzi6S4xDhvZBbO2bFabiRJKXiodTqDTTqNv8o4xECGJv1BN4PTS1aQd2EDSp0KRDNN_8_38ewZPZ1a8Lc_H98uchPB3c3uh6C7t9t_LvUA_qi_ehn98Cp8n7_w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Progress+in+Nucleic+Acid+Research+and+Molecular+Biology&rft.atitle=Distinct+Regulatory+Properties+of+Pyruvate+Dehydrogenase+Kinase+and+Phosphatase+Isoforms&rft.date=2001-01-01&rft.pub=Elsevier+Science+%26+Technology&rft.isbn=9780125400701&rft.volume=70&rft_id=info:doi/10.1016%2FS0079-6603%2801%2970013-X&rft.externalDBID=44&rft.externalDocID=EBC298281_18_44
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Febookcentral.proquest.com%2Fcovers%2F298281-l.jpg